Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.
Novartis to Buy MorphoSys for $2.9 Billion; Deal Seen Closing in 1H Novartis said the acquisition expands and complements its pipeline in oncology.
Virgin Galactic Reports Flight Issue to.